Scientists reprogram Patients' own cells to hunt advanced cancers
NCT ID NCT01697527
Summary
This study is testing a two-part treatment for advanced cancer. Doctors take a patient's own white blood cells, genetically modify them to recognize a specific cancer protein (NY-ESO-1), and infuse them back. This is combined with a vaccine made from the same protein to boost the immune attack. The goal is to see if this personalized cell therapy can safely shrink tumors in patients who have run out of standard treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALIGNANT NEOPLASM are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of California at Los Angeles (UCLA )
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.